OPRX OptimizeRx Corporation logo

OPRX OptimizeRx Corporation

Healthcare
$4.94+0.00%ClosedMarket Cap: $92.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

24.31

PEG

0.19

P/B

0.72

P/S

0.86

EV/EBITDA

5.12

DCF Value

$-12.92

FCF Yield

15.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

69.0%

Operating Margin

13.6%

Net Margin

6.4%

ROE

5.5%

ROA

4.1%

ROIC

6.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$19.8M$-495.0K$
Q4 null$32.2M$5.0M$
FY null$109.4M$5.1M$
Q3 null$26.1M$779.0K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$10.50

Target (Median)

$10.50

Target Range

$7.00 - $14.00

1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Stephens & Co.Equal Weight
2026-05-13
StifelBuy
2026-05-13
Lake StreetBuy
2026-05-13
B. Riley SecuritiesBuy
2026-05-13
Lake StreetBuy
2026-03-06

Trading Activity

Insider Trades

View All
Silvestro Stephen Lofficer: Chief Executive Officer
SellMon May 18
Greco Theresaofficer: Chief Commercial Officer
SellMon May 18
Greco Theresaofficer: Chief Commercial Officer
SellMon May 18
Presti Mariyamma Varghesedirector:
SellWed Apr 22
Odence-Ford Marionofficer: Chief Legal & Admin Officer
SellFri Feb 13

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

Beta

1.19

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Peers